This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


DPA on the Rise


Continued from page 1


1. Herold PM, Kinsella JE. “Fish oil consumption and decreased risk of cardiovascular disease - a comparison of findings from animal and human feeding trials.” Am J Clin Nutr. 1986;43(4):566-598.

2. Paganelli F et al. “Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease.” Int J Cardiol. 2001;78(1):27-32.

3. Sun Q et al. “Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction.” Am J Clin Nutr. 2008;88(1):216-223.

4. Leng GC et al. “Plasma essential fatty-acids, cigarette-smoking, and dietary antioxidants in peripheral arterial-disease - a population-based case-control study.” Arteriosclerosis Thrombosis. 1994;14(3):471-478.

5. Assies J et al. “Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.” Biological Psychiatry. 2001;49(6):510-522.

6. Milte CM et al. “Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls.” Prostagland Leukotriene Essen Fatty Acids. 2011;84(5-6):153-161.

7. Ritch CR et al. “Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men.” J Urol. 2007;177(1):97-101.

8. Pawlosky RJ, Salem N. “Ethanol exposure causes a decrease in docosahexaenoic acid and an increase in docosapentaenoic acid in feline brains and retinas.” Am J Clin Nutr. 1995;61(6):1284-1289.

9. Hino A et al. “Very long chain n-3 fatty acids intake and carotid atherosclerosis: An epidemiological study evaluated by ultrasonography.” Atheroscler. 2004;176(1):145-149.

10. Kaur G et al. “Short-term docosapentaenoic acid (22:5n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats.” Br J Nutr. 2011;103(1):32-37.

11. Akiba S, Murata T, Kitatani K, Sato T. “Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation.” Biol Pharmaceutical Bull. 2000;23(11):1293-1297.

12. Kanayasu Toyoda T, Morita I, Murota S. “Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro.” Prostaglandins Leukotriene Essent Fatty Acids. 1996;54(5):319-325.

13. Kelly L et al. “The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat.” Neurobiology of Aging; In Press, Corrected Proof.

« Previous12Next »
comments powered by Disqus